SenolyticsJAMA Ophthalmology · 9 Aug 2026
Signal74·NotableSenolytic eye therapy holds effect at 36 weeks in Phase 2b
A locally delivered senolytic maintained vision gains at 36 weeks in diabetic macular edema, with fewer re-injections than standard anti-VEGF therapy.…
EvidenceModerateMarket relevanceMedium5 min read
